The Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
Dig Dis Sci. 2012 Feb;57(2):311-9. doi: 10.1007/s10620-011-1897-2. Epub 2011 Sep 8.
Growing evidence suggests that patients with post-infectious irritable bowel syndrome (PI-IBS) have increased mast cell activation, and that mucosal soluble mediators are involved in the pathophysiology of visceral hyperalgesia. In addition, previous findings show that reactive oxygen species (ROS) and protease-activated receptors (PARs) are mediators of persistent hyperalgesia.
This article aims to investigate: (1) the ability of soluble factors from colonic biopsies to active peritoneal mast cells (PMCs) in vitro; (2) whether the effects of PMCs degranulation induced by soluble mediators are related to PARs activation; and (3) the ability of phenyl N-tert-butylnitrone (PBN), a ROS scavenger, to modify these alterations.
Supernatant (SUP) from colonic biopsies was collected and applied to PMCs for 12 h. Activation of PMCs was evaluated. The expression of PAR(2) in PMCs was examined by RT-PCR and double-immunofluorescence staining. PBN (10 mM) treatment was administered, then previous alterations were observed again.
Stimulation with SUP of PI-IBS led to an increase in activation of PMCs. PAR(2)mRNA expression was significantly increased in PMCs induced by SUP of PI-IBS compared to healthy subjects. After being treated by PBN, the SUP-induced enhancement of PMCs activities could be weakened, and PAR(2)mRNA expression was significantly decreased. A similar result of immunoreactivity for PAR(2) was observed in PMCs.
The study shows that ROS scavenger reverses the SUP of PI-IBS-induced enhancement of PMCs activities, and that these effects may be related to activation of PAR(2). These findings might pave the way to new therapeutic targets in PI-IBS.
越来越多的证据表明,感染后肠易激综合征(PI-IBS)患者存在肥大细胞激活增加,黏膜可溶性介质参与内脏痛觉过敏的病理生理过程。此外,先前的研究结果表明,活性氧(ROS)和蛋白酶激活受体(PARs)是持续性痛觉过敏的介质。
本文旨在研究:(1)结肠活检可溶性因子在体外激活腹膜肥大细胞(PMCs)的能力;(2)可溶性介质诱导 PMCs 脱颗粒的作用是否与 PARs 激活有关;(3)ROS 清除剂苯甲硝酮(PBN)修饰这些改变的能力。
收集结肠活检的上清液(SUP)并应用于 PMCs 12 小时。评估 PMCs 的激活情况。通过 RT-PCR 和双免疫荧光染色检测 PMCs 中 PAR(2)的表达。给予 PBN(10 mM)处理,然后再次观察先前的改变。
PI-IBS 的 SUP 刺激导致 PMCs 激活增加。与健康受试者相比,PI-IBS 的 SUP 诱导的 PMCs 中 PAR(2)mRNA 表达明显增加。用 PBN 处理后,SUP 诱导的 PMCs 活性增强可减弱,PAR(2)mRNA 表达明显降低。PMCs 中 PAR(2)的免疫反应性也观察到类似的结果。
该研究表明,ROS 清除剂可逆转 PI-IBS 的 SUP 诱导的 PMCs 活性增强,这些作用可能与 PAR(2)的激活有关。这些发现可能为 PI-IBS 开辟新的治疗靶点。